Sunday, November 19, 2006
Print Current Day:
|
|
SESSION XXXIII SCHEDULE | |
SESSION XXXIII:
RECENT ADVANCES AND UPDATES (7-MINUTE TALKS)
Moderators:Thomas S. Riles, M.D. / Dhiraj M. Shah, M.D.
|
|
x | |
6:40 AM - 6:47 AM | Vascular Challenges After Blunt Trauma To The Thoracic Aorta: Principles In Management And Optimal Techniques For Repair |
Presenters: Kenneth L. Mattox, M.D. | |
6:48 AM - 6:55 AM | Contemporary Management Of A-V Malformations With A Multidisciplinary Approach |
Presenters: Byung-Boong Lee, M.D. | |
6:56 AM - 7:03 AM | Why Renal Arteries Get Covered During EVAR: How To Avoid This Mishap |
Presenters: James May, M.D., M.S., F.R.A.C.S., F.A.C.S. | |
7:04 AM - 7:11 AM | Update On The CardioMems Implantable Pressure Sensor For EVAR: Advantages And Limitations |
Presenters: Ross Milner, M.D. | |
7:12 AM - 7:19 AM | Direct Intrasac Pressure Measurements Of Selected Patients After EVAR Suggest Long-Term Intrasac Pressure Telemetry May Not Replace Conventional Surveillance Imaging Techniques |
Presenters: Martin Malina, M.D., Ph.D. | |
7:20 AM - 7:27 AM | Tissue Engineered Vascular Grafts: Will They Ever Work? |
Presenters: Bo Risberg, M.D., Ph.D. | |
7:28 AM - 7:37 AM | Panel Discussion |
Moderator(s): James F. McKinsey, M.D. / Robert B. Rutherford, M.D. | |
7:38 AM - 7:45 AM | Treatment Strategies For Type II Endoleaks: How My Thoughts Have Changed |
Presenters: Richard A. Baum, M.D. | |
7:46 AM - 7:53 AM | What I Have Learned About Type II Endoleaks: How Benign They Are; And How To Detect Them |
Presenters: Kim J. Hodgson, M.D. | |
7:54 AM - 8:01 AM | The Fate Of Endoleaks Detected By CT But Not Detected By Color Flow Duplex Ultrasonography After EVAR: Can They Be Ignored? |
Presenters: Ali F. AbuRahma, M.D. | |
8:02 AM - 8:09 AM | Type II Endoleaks Are Not So Benign After All: They Can Produce AAA Rupture Without An Associated Type I Endoleak |
Presenters: David C. Brewster, M.D. | |
8:10 AM - 8:17 AM | Endovascularly Placed CANCION Device For The Treatment Of Refractory Congestive Heart Failure |
Presenters: Steven F. Bolling, M.D. | |
8:18 AM - 8:24 AM | Panel Discussion |
END OF SESSION XXXIII | |
SESSION XXXIV SCHEDULE | |
SESSION XXXIV:
MORE NEW INFORMATION ON ANEURYSMS AND THORACIC AORTIC DISEASE (7-MINUTE TALKS)
Moderators:Daniel G. Clair, M.D.
|
|
x | |
8:25 AM - 8:30 AM | DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion |
Presenters: William P. Paaske, M.D., DrMedSci, FRCS, FRCS Ed, FACS | |
8:31 AM - 8:36 AM | DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - Against The Motion |
Presenters: Marc R.H. van Sambeek, M.D., Ph.D. | |
8:37 AM - 8:45 AM | DEBATE: With Ruptured AAA, Endo Repair Is Best For Most Patients - For The Motion |
Presenters: Christos D. Liapis, M.D. | |
8:46 AM - 8:53 AM | The Relay Thoracic Endograft: Technique And Early Results With A New Kind Of Stent-Graft Which Facilitates Easy Precise Placement In A Tortuous Proximal Aortic Arch |
Presenters: Vicente Riambau, M.D., Ph.D. | |
8:54 AM - 9:01 AM | EUROSTAR Real World Experience With Thoracic Endografts: Is It A Cause For Optimism Or A Cause For Concern? |
Presenters: Peter L. Harris, M.D., F.R.C.S. | |
9:02 AM - 9:09 AM | Two- And Three-Dimensional Criteria For Estimating AAA Rupture Risk |
Presenters: Mark F. Fillinger, M.D. | |
9:10 AM - 9:17 AM | The Need To Include "Best Medical Care In Trials Evaluating Carotid Angioplasty And Stenting" |
Presenters: Anthony J. Comerota, M.D., F.A.C.S. | |
9:18 AM - 9:25 AM | The VALOR Trial Of Talent Endografts For A Variety Of Thoracic Aortic Lesions In High Risk Patients: The Real World Experience |
Presenters: Mark A. Farber, M.D. | |
9:26 AM - 9:33 AM | Debate: IVUS Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations? |
Presenters: Rodney A. White, M.D. | |
9:34 AM - 9:41 AM | Debate: Transesophageal Echo Is The Best Adjunctive Method For Performing Thoracic Endografting: What Are Its Limitations? |
Presenters: Dietmar H. Koschyk, M.D. | |
9:42 AM - 9:49 AM | Low Permeability Modifications Of The Gore Excluder And TAG Grafts Affect AAA And TAA Sac Behavior In A Beneficial Way |
Presenters: Thomas C. Naslund, M.D. | |
9:50 AM - 10:00 AM | Panel Discussion |
END OF SESSION XXXIV | |
SESSION XXXV SCHEDULE | |
SESSION XXXV:
NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID, VERTEBRAL AND SUPRA-AORTIC TRUNK DISEASE (7-MINUTE TALKS)
Moderators:Frank J. Veith, M.D.
|
|
x | |
10:01 AM - 10:08 AM | Factors Correlating With Restenosis After CEA: Can They Be Modified And Decrease Restenosis? |
Presenters: Glenn M. LaMuraglia, M.D. | |
10:09 AM - 10:16 AM | Natural History Of Carotid Artery Occlusion Contralateral To A CEA: It’s More Benign Than We Thought |
Presenters: Ali F. AbuRahma, M.D. | |
10:17 AM - 10:24 AM | Update On Results Of The CAPTURE Trial: What Does It Mean In The CAS Versus CEA Debate? |
Presenters: Ronald M. Fairman, M.D. | |
10:25 AM - 10:32 AM | Mini Skin Incision For CEA: A Safe Alternative To The Standard Approach: Indications And Contraindications |
Presenters: Enrico Ascher, M.D. | |
10:33 AM - 10:40 AM | Vertebral PTA And Stenting With Embolic Protection: How To Do It And Is It Necessary? |
Presenters: Karthikeshwar Kasirajan, M.D. | |
10:41 AM - 10:48 AM | Is Carotid Plaque Morphology Or Degree Of Stenosis More Important In Determining Prognosis Of An Individual Lesion In Terms Of Natural History; In Terms Of CAS? |
Presenters: Frans L. Moll, M.D., Ph.D. | |
10:49 AM - 10:56 AM | Intraoperative Imaging After CEA Does Not Improve Outcomes |
Presenters: Caron B. Rockman, M.D. | |
10:57 AM - 11:04 AM | Tips And Tricks For Managing Carotid Body Tumors |
Presenters: Wesley S. Moore, M.D. | |
11:05 AM - 11:13 AM | Panel Discussion |
END OF SESSION XXXV | |
SESSION XXXVI SCHEDULE | |
SESSION XXXVI:
OTHER NEW DEVELOPMENTS IN STENTING OF THE CAROTID BIFURCATION AND SUPRA-AORTIC TRUNKS (6- AND 7-MINUTE TALKS)
Moderators:Juan C. Parodi, M.D.
|
|
x | |
11:14 AM - 11:21 AM | When Should We Attempt To Open An Occluded Carotid Or Vertebral Artery? How Should It Be Done? |
Presenters: L. Nelson Hopkins, M.D. | |
11:22 AM - 11:29 AM | Transcervical Approach To CAS: 3-Year Follow-Up Of 100 Patients: Should It Be A Routine Approach? |
Presenters: Enrique Criado, M.D., F.A.C.S. | |
11:30 AM - 11:37 AM | Why Are Randomized Clinical Data The Only Way To Compare The Outcomes Of CAS With Those Of CEA? Do We Yet Have Any Valid Comparative Outcome Results From Anywhere In The Globe? |
Presenters: Robert W. Hobson II, M.D. | |
11:38 AM - 11:44 AM | Debate: Carotid Stenting Is Ready For General Acceptance And Usage |
Presenters: Mark H. Wholey, M.D. | |
11:45 AM - 11:51 AM | Debate: Carotid Stenting Is Not Ready For General Acceptance And Usage |
Presenters: Marc Bosiers, M.D. | |
11:52 AM - 11:59 AM | What Are The Real World Current Stroke And Death Rates For CEA Based On 2 Statewide Studies? How Do They Impact On The Present Role For CAS? |
Presenters: Bruce A. Perler, M.D., M.B.A. | |
12:00 PM - 12:07 PM | Ischemic Preconditioning To Facilitate Use Of Balloon Embolic Protection (With The PercuSurge Device) When It Is Poorly Tolerated During CAS: How Can This Work And Should The Principle Be Used More Generally? |
Presenters: Peter L. Faries, M.D. | |
12:08 PM - 12:18 PM | Panel Discussion |
END OF SESSION XXXVI | |
SESSION XXXVII SCHEDULE | |
SESSION XXXVII:
UPDATES, NEW CONCEPTS, ADVANCES AND LATE BREAKING TRIALS (6-MINUTE TALKS)
Moderators:Dhiraj M. Shah, M.D. / John J. Ricotta, M.D.
|
|
x | |
12:19 PM - 12:26 PM | Open Minimally Invasive Limb Salvage Procedures: A Less Morbid Approach |
Presenters: Peter F. Lawrence, M.D. | |
12:27 PM - 12:33 PM | How To Deal Surgically With A Heavily And Circumferentially Calcified (Porcelain) Aorta |
Presenters: Olivier A. Goëau-Brissonnière, M.D., Ph.D. | |
12:34 PM - 12:40 PM | What Effects Beyond Cholesterol Lowering Do Statin Drugs Have In Vascular Disease Patients? |
Presenters: Ralph G. DePalma, M.D. | |
12:41 PM - 12:47 PM | What’s New To Facilitate The Endovascular Treatment Of Traumatic Vascular Lesions? |
Presenters: Jan S. Brunkwall, M.D., Ph.D. | |
12:48 PM - 12:54 PM | Two-Year Results Of The European Superficial Femoral Artery Registry (ESFAR): Lessons Learned |
Presenters: Gerhard Hoffmann, M.D. | |
12:55 PM - 1:01 PM | Which Graft Is Best For Femorofemoral Bypass - Dacron Or PTFE? Based On Results Of A Randomized Trial In 198 Patients |
Presenters: Torben V. Schroeder, M.D., D.M.Sc. | |
1:02 PM - 1:08 PM | Isolated Limb Perfusion With Lytic Drugs Can Improve Limb Salvage After Acute Thromboembolism With Extensive Involvement Of Infrapopliteal Arteries |
Presenters: John F. Eidt, M.D. | |
1:09 PM - 1:15 PM | Influence Of Real-Time Hemodynamic Monitoring On The Outcome Of EVAR For Ruptured AAAs |
Presenters: J. Adam van der Vliet, M.D. | |
1:16 PM - 1:22 PM | Vascular Abnormalities In Patients With Neurofibromatosis: What The Vascular Surgeon Needs To Know |
Presenters: Peter Gloviczki, M.D. | |
1:23 PM - 1:33 PM | Panel Discussion |
Moderator(s): Michael B. Silva, Jr., M.D. / Frank J. Veith, M.D. | |
1:34 PM - 1:40 PM | The Boomerang Device For Closure Of Arterial Punctures: Advantages And Limitations |
Presenters: Ali Amin, M.D., F.A.C.S., F.A.C.C., R.V.T. | |
1:41 PM - 1:47 PM | Is An Iliac Occlusion A Contraindication To EVAR? Techniques To Solve The Problem |
Presenters: William D. Jordan, Jr., M.D. | |
1:48 PM - 1:54 PM | New Methods And Adjuncts To Expand The Indications For EVAR |
Presenters: Jacques Bleyn, M.D. | |
1:55 PM - 2:01 PM | Chronic Spinal Cord Injury Increases Aortic Diameter And AAA Formation: What Is The Mechanism? |
Presenters: Ronald L. Dalman, M.D. | |
2:02 PM - 2:08 PM | Optimal Management Of Paget-Schroetter Syndrome: Does Lysis And Conservative Treatment Work And When Is Rib Resection And Stenting Indicated? |
Presenters: Matthew J. Eagleton, M.D. | |
2:09 PM - 2:15 PM | Complications And Outcomes Associated With Use Of Retrievable IVC Filters: Do The Devices Make A Difference Based On The Collected FDA Data? |
Presenters: Palma M. Shaw, M.D. | |
2:16 PM - 2:22 PM | Spontaneous Dissection Of The Abdominal Aorta: Clinical Presentation And Best Therapeutic Options: Open Surgical Versus Endovascular |
Presenters: Mark A. Farber, M.D. | |
2:23 PM - 2:29 PM | Late Breaking Development: Aptus AAA Endograft With Proximal Fixation Staples |
Presenters: David H. Deaton, M.D. | |
2:30 PM - 2:40 PM | Panel Discussion |
2:40 PM - 2:45 PM | Prize Drawing Raffle - $8.000 In Prizes. You Must Be Present To Win! |
2:45 PM - 2:45 PM | Symposium Ends. SAVE-THE-DATE: Wednesday, November 14 - Sunday, November 18, 2007. SHERATON NEW YORK HOTEL & TOWERS. PLEASE COME AGAIN. |
END OF SESSION XXXVII |